Ligand Pharmaceuticals Incorporated LGNDZ Company

New Post Public Reply Private Reply Replies (0) Message Board

Aug 31, 2013 at 10:15 PM

Ligand Pharmaceuticals Incorporated LGNDZ Company Overview

Stock Message Board http://investorshangout.com/search?q=LGNDZ&am...mp;yt1=Go!

Ligand Pharmaceuticals Incorporated LGNDZ Current Price and Quotes
0.0185
Previous Close
0.0185
Open
N/A

Daily Range
N/A - N/A
52wk Range
0.03 - 0.01

Volume
0
Dividend
N/A

Average Vol (3m)
3,559
Yield
N/A

Ligand Pharmaceuticals Incorporated LGNDZ
Company Information
11119 North Torrey Pines Road
Suite 200
La Jolla, CA 92037

Website: http://www.ligand.com
Phone: 858-550-7500

Ligand Pharmaceuticals Incorporated LGNDZ
Ligand discovers, develops and markets new drugs for critical unmet medical needs in the areas of cancer, pain, skin diseases, hormone-related diseases, osteoporosis, metabolic disorders, cardiovascular and inflammatory diseases. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology related to intracellular receptors.

Ligand Pharmaceuticals Incorporated LGNDZ
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Not Available
Latest Report Jun 30, 2013 10-Q
CIK 0000886163
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 1987
Employees 550 a/o Dec 31, 2004
Company Officers/Contacts
David E. Robinson President, CEO
Paul V. Maier CFO
Matthew W. Foehr EVP, COO
Charles S. Berkman Vice President, Secretary, General Counsel
Erika Luib IR
Company Directors
David E. Robinson Chairman
John LaMattina
Sunil Patel
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Ligand Pharmaceuticals Incorporated LGNDZ
LGNDZ Security Details Other Company Securities
Share Structure
Market Value1 Not Available
Shares Outstanding Not Available
Float Not Available
Authorized Shares Not Available
Par Value No Par Value
Shareholders
Shareholders of Record Not Available
Corporate Actions
Ex. Date Record Date Pay Date
Dividend (0.07633) Jul 02, 2010 Jun 28, 2010 Jul 01, 2010
Dividend (0.07633) Jul 02, 2010 Jun 28, 2010 Jul 01, 2010
Dividend (0.076) Jul 02, 2010 Jun 28, 2010 Jul 01, 2010
Short Selling Data
Short Interest 0 (-100%)
May 15, 2012
Significant Failures to Deliver No
Transfer Agent(s)

Ligand Pharmaceuticals Incorporated LGNDZ Recent News

Aug 14, 2013 Ligand Enters Global License Agreement with CURx Pharmaceuticals, Inc. for Captisol-Enabled(TM) Topiramate Injection
Aug 1, 2013 Ligand Reports Second Quarter Financial Results
Jul 29, 2013 New License Agreements and Financial Results Release - Research Report on Elan, Waters, InterMune, Spectranetics, and Ligand
Jul 26, 2013 Ligand Partner GlaxoSmithKline Receives Positive CHMP Opinion for REVOLADE(TM) in Thrombocytopenia Associated with Chronic Hepatitis C Infection
Jul 26, 2013 Ligand Receives Orphan Designation for Captisol-Enabled(TM) Topiramate Injection
Jul 24, 2013 Ligand Signs License Agreement with Ethicor for Oral Lasofoxifene
Jul 22, 2013 Ligand Signs Global License Agreement with Azure for Lasofoxifene
Jul 17, 2013 Ligand to Report Second Quarter Results on August 1st
Jun 24, 2013 Ligand Announces Positive Preclinical Data for Glucagon Program in Model of Type 1 Diabetes
Jun 20, 2013 Ligand Raises Ownership Limit for BVF Partners to 25% of Shares Outstanding

Ligand Pharmaceuticals Incorporated LGNDZ Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 31,388 30,037 23,538 38,940
Cost of Revenue 3,601 4,909 - -
Gross Profit 27,787 25,128 23,538 38,940
Operating Expenses
Research and Development 10,790 10,291 22,067 39,870
Sales, General and Admin. 16,108 13,275 11,127 (6,640)
Non-Recurring Items 315 2,260 19,648 15,677
Other - - - -
Operating Income 574 (698) (29,304) (9,967)
Income From Continuing Operations
Add'l Income/Expense Items (1,134) (383) 13,519 365
Earnings Before Interest and Tax (3,865) (3,558) (15,403) (9,602)
Interest Expense - - - 270
Earnings Before Tax (3,865) (3,558) (15,403) (9,872)
Income Tax (1,191) (13,270) (2,617) (1,535)
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (2,674) 9,712 (12,786) (8,337)
Non Recurring Events
Discontinued Operations 2,147 3 2,413 6,389
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (527) 9,715 (10,373) (1,948)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (527) 9,715 (10,373) (1,948)

LGNDZ Ligand Pharmaceuticals Incorporated Research DD Guide

LGNDZ Ligand Pharmaceuticals Incorporated Stock Message Board http://investorshangout.com/search?q=LGNDZ&am...mp;yt0=Go!
LGNDZ Ligand Pharmaceuticals Incorporated Stock Quote http://www.otcmarkets.com/stock/LGNDZ/quote
LGNDZ Ligand Pharmaceuticals Incorporated Stock Chart http://www.otcmarkets.com/stock/LGNDZ/chart
LGNDZ Ligand Pharmaceuticals Incorporated Company Info http://www.otcmarkets.com/stock/LGNDZ/company-info
LGNDZ Ligand Pharmaceuticals Incorporated Recent News http://www.otcmarkets.com/stock/LGNDZ/news
LGNDZ Ligand Pharmaceuticals Incorporated Financials http://www.otcmarkets.com/stock/LGNDZ/financials
LGNDZ Ligand Pharmaceuticals Incorporated Filings and Disclosure http://www.otcmarkets.com/stock/LGNDZ/filings
LGNDZ Ligand Pharmaceuticals Incorporated Short Sales http://www.otcmarkets.com/stock/LGNDZ/short-sales
LGNDZ Ligand Pharmaceuticals Incorporated Insider Disclosure http://www.otcmarkets.com/stock/LGNDZ/insider-transactions
LGNDZ Ligand Pharmaceuticals Incorporated Research Reports http://www.otcmarkets.com/stock/LGNDZ/research
LGNDZ Ligand Pharmaceuticals Incorporated Summary http://finance.yahoo.com/q?s=LGNDZ
LGNDZ Ligand Pharmaceuticals Incorporated Historical Prices http://finance.yahoo.com/q/hp?s=LGNDZ+Historical+Prices
LGNDZ Ligand Pharmaceuticals Incorporated Interactive Chart http://finance.yahoo.com/echarts?s=LGNDZ
LGNDZ Ligand Pharmaceuticals Incorporated Basic Chart http://finance.yahoo.com/q/bc?s=LGNDZ+Basic+Chart
LGNDZ Ligand Pharmaceuticals Incorporated Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=LGNDZ+Basic+Tech.+Analysis
LGNDZ Ligand Pharmaceuticals Incorporated Headlines http://finance.yahoo.com/q/h?s=LGNDZ+Headlines
LGNDZ Ligand Pharmaceuticals Incorporated Press Releases http://finance.yahoo.com/q/p?s=LGNDZ+Press+Releases
LGNDZ Ligand Pharmaceuticals Incorporated Company Profile http://finance.yahoo.com/q/pr?s=LGNDZ+Profile
LGNDZ Ligand Pharmaceuticals Incorporated Key Statistics http://finance.yahoo.com/q/ks?s=LGNDZ+Key+Statistics
LGNDZ Ligand Pharmaceuticals Incorporated Industry http://finance.yahoo.com/q/in?s=LGNDZ+Industry
LGNDZ Ligand Pharmaceuticals Incorporated Major Holders http://finance.yahoo.com/q/mh?s=LGNDZ+Major+Holders
LGNDZ Ligand Pharmaceuticals Incorporated Insider Transactions http://finance.yahoo.com/q/it?s=LGNDZ+Insider+Transactions
LGNDZ Ligand Pharmaceuticals Incorporated Insider Roster http://finance.yahoo.com/q/ir?s=LGNDZ+Insider+Roster
LGNDZ Ligand Pharmaceuticals Incorporated Income Statement http://finance.yahoo.com/q/is?s=LGNDZ
LGNDZ Ligand Pharmaceuticals Incorporated Balance Sheet http://finance.yahoo.com/q/bs?s=LGNDZ
LGNDZ Ligand Pharmaceuticals Incorporated Cash Flow http://finance.yahoo.com/q/cf?s=LGNDZ+Cash+Flow&annual
LGNDZ Ligand Pharmaceuticals Incorporated Nasdaq http://www.nasdaq.com/symbol/LGNDZ
LGNDZ Ligand Pharmaceuticals Incorporated Market Watch http://www.marketwatch.com/investing/stock/LGNDZ
LGNDZ Ligand Pharmaceuticals Incorporated Bloomberg http://www.bloomberg.com/quote/LGNDZ:US
LGNDZ Ligand Pharmaceuticals Incorporated Morningstar http://quotes.morningstar.com/stock/s?t=LGNDZ
LGNDZ Ligand Pharmaceuticals Incorporated Bussinessweek http://investing.businessweek.com/research/st...cker=LGNDZ
LGNDZ Ligand Pharmaceuticals Incorporated Barchart http://www.barchart.com/quotes/stocks/LGNDZ
LGNDZ Ligand Pharmaceuticals Incorporated OTC Short Report http://otcshortreport.com/index.php?index=LGNDZ
LGNDZ Ligand Pharmaceuticals Incorporated Investopedia http://www.investopedia.com/markets/stocks/LGNDZ/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gildan Activewear Faces Legal Battle Over Alleged Fraud

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

D-Wave Investors Must Decide by Dec 15 Class Suit

Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...

TORRAS Cases Balance Protection with Slim Design for 2026

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Love Business Group Helps SMEs Navigate Broadband Choices

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Sinclair Faces Labor Lawsuit for Break-time Violations

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Community in Shock After Fatal Bakersfield Shooting

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...